Defining the role of AP1 in molecular adaptation to hypoxia in colorectal cancer

Defining the role of AP1 in molecular adaptation to hypoxia in colorectal cancer

Bibliografische gegevens
Hoofdauteurs:	Vancauwenberghe, E, Bolland, H, Carroll, C, Da Motta, L, Grabowska, A, Buffa, F, Harris, A, McIntyre, A
Formaat:	Conference item
Taal:	English
Gepubliceerd in:	American Association for Cancer Research 2019

Gelijkaardige items

The tumour hypoxia induced non-coding transcriptome.
door: Choudhry, H, et al.
Gepubliceerd in: (2016)

Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia
door: Haider, S, et al.
Gepubliceerd in: (2016)

The role of hypoxia regulated microRNAs in cancer.
door: McCormick, R, et al.
Gepubliceerd in: (2010)

Gene expression and hypoxia in breast cancer.
door: Favaro, E, et al.
Gepubliceerd in: (2011)

Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis.
door: Jubb, A, et al.
Gepubliceerd in: (2010)

Gene expression signatures as biomarkers of tumour hypoxia
door: Harris, B, et al.
Gepubliceerd in: (2015)

Metabolic and hypoxic adaptation to anti‐angiogenic therapy: a target for induced essentiality
door: Alan McIntyre, et al.
Gepubliceerd in: (2015-02-01)

The prognostic value of hypoxia, proliferation and radiation sensitivity gene signatures: Toward a "molecular treatment planning system"
door: Starmans, M, et al.
Gepubliceerd in: (2006)

In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
door: Abu-Jamous, B, et al.
Gepubliceerd in: (2017)

Proline-hydroxylated hypoxia-inducible factor 1a (HIF-1a) upregulation in human tumours
door: Snell, C, et al.
Gepubliceerd in: (2014)

Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer.
door: Koukourakis, M, et al.
Gepubliceerd in: (2006)

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene.
door: Buffa, F, et al.
Gepubliceerd in: (2010)

The effects of chemotherapy agents on hypoxia in colorectal cancer
door: Siddiky, A
Gepubliceerd in: (2015)

Disrupting hypoxia-induced bicarbonate transport acidifies tumor cells and suppresses tumor growth
door: McIntyre, A, et al.
Gepubliceerd in: (2016)

Hypoxia-induced switch in SNAT2/SLC38A2 regulation generates endocrine resistance in breast cancer
door: Morotti, M, et al.
Gepubliceerd in: (2019)

An Experimentally Defined Hypoxia Gene Signature in Glioblastoma and Its Modulation by Metformin
door: Marta Calvo Tardón, et al.
Gepubliceerd in: (2020-09-01)

The process of adapting an online induction course to support distinct student cohorts
door: Kirsty McIntyre, et al.
Gepubliceerd in: (2022-09-01)

Mild intermittent hypoxia exposure induces metabolic and molecular adaptations in men with obesity
door: Rens L.J. van Meijel, et al.
Gepubliceerd in: (2021-11-01)

Two color imaging of different hypoxia levels in cancer cells
door: Wallabregue, ALD, et al.
Gepubliceerd in: (2023)

Novel hypoxia- and lactate metabolism-related molecular subtyping and prognostic signature for colorectal cancer
door: An Huang, et al.
Gepubliceerd in: (2024-06-01)

The BET inhibitor JQ1 selectively impairs tumour response to hypoxia and downregulates CA9 and angiogenesis in triple negative breast cancer (TNBC)
door: Harris, A, et al.
Gepubliceerd in: (2016)

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia.
door: Koukourakis, M, et al.
Gepubliceerd in: (2010)

Oxali(IV)Fluors: fluorescence responsive oxaliplatin(IV) complexes identify a hypoxia-dependent reduction in cancer cells
door: Boulet, M, et al.
Gepubliceerd in: (2023)

Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis
door: Knowles, H, et al.
Gepubliceerd in: (2001)

Hypoxia and oxidative stress in breast cancer. Hypoxia and tumourigenesis.
door: Knowles, H, et al.
Gepubliceerd in: (2001)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3.
door: Ramachandran, A, et al.
Gepubliceerd in: (2013)

An in vivo hypoxia metagene identifies the novel hypoxia inducible factor target gene SLCO1B3
door: Ramachandran, A, et al.
Gepubliceerd in: (2013)

Aps: an itinerary for competences in the subject of adapted sport
door: José Manuel Puchalt Hernández
Gepubliceerd in: (2020-06-01)

In vitro downregulated hypoxia transcriptome is associated with poor prognosis in breast cancer
door: Basel Abu-Jamous, et al.
Gepubliceerd in: (2017-06-01)

Regulation of autophagy by ATF4 in response to severe hypoxia.
door: Rzymski, T, et al.
Gepubliceerd in: (2010)

Are there specific molecular adaptations of skeletal muscle to repeated sprint training in hypoxia?
door: Clément Lanfranchi, et al.
Gepubliceerd in: (2024-02-01)

Significant molecular and systemic adaptations after repeated sprint training in hypoxia.
door: Raphael Faiss, et al.
Gepubliceerd in: (2013-01-01)

Anti-apoptotic role of HIF-1 and AP-1 in paclitaxel exposed breast cancer cells under hypoxia
door: Raes Martine, et al.
Gepubliceerd in: (2010-07-01)

Adaptation of mammals to hypoxia
door: Fang Li, et al.
Gepubliceerd in: (2021-12-01)

Survival Pathways of HIF-Deficient Tumour Cells: TCA Inhibition, Peroxisomal Fatty Acid Oxidation Activation and an AMPK-PGC-1α Hypoxia Sensor
door: Monika A. Golinska, et al.
Gepubliceerd in: (2022-11-01)

Prediction of immunotherapy efficacy and immunomodulatory role of hypoxia in colorectal cancer
door: Zhuangzhuang Zheng, et al.
Gepubliceerd in: (2022-11-01)

Links between the unfolded protein response and the DNA damage response in hypoxia: a systematic review
door: Bolland, H, et al.
Gepubliceerd in: (2021)

Large meta-analysis of multiple cancers reveals a common, compact and highly prognostic hypoxia metagene (British Journal of Cancer (2010) 102 (428435) DOI:10.1038/sj.bjc.6605450))
door: Buffa, F, et al.
Gepubliceerd in: (2010)

Proline-hydroxylated hypoxia-inducible factor 1α (HIF-1α) upregulation in human tumours.
door: Cameron E Snell, et al.
Gepubliceerd in: (2014-01-01)

A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer.
door: Eustace, A, et al.
Gepubliceerd in: (2013)